Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Gauri A Varadhachary

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5082773114. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 8

  1. Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Pha… Co-author DOI 10.1001/jamaoncol.2021.0006↗
  2. Medical oncology and pancreatic cancer: what the radiologist needs to know. First author DOI 10.1007/s00261-017-1432-9↗
  3. 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-0831↗
  4. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cance… Co-author DOI 10.1007/s11605-013-2374-3↗
  5. Management of borderline resectable pancreatic cancer. Last author DOI 10.1016/j.semradonc.2013.11.006↗
  6. The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer. Co-author DOI 10.1007/s10637-013-9967-2↗
  7. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Co-author DOI 10.1002/cncr.27636↗
  8. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. Co-author DOI 10.1111/j.1477-2574.2012.00445.x↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David R. Fogelman · 3 shared papers, 2013–2021 · strength 0.33
  2. Robert A. Wolff · 4 shared papers, 2012–2021 · strength 0.22
  3. Milind M. Javle · 3 shared papers, 2013–2021 · strength 0.21
  4. Matthew H. G. Katz · 4 shared papers, 2012–2014 · strength 0.16
  5. Jason B. Fleming · 4 shared papers, 2012–2017 · strength 0.14
  6. Christopher H. Crane · 3 shared papers, 2012–2014 · strength 0.13
  7. Talia Golan · 1 shared paper, 2021 · strength 0.12
  8. Ben Boursi · 1 shared paper, 2021 · strength 0.12
  9. Jean‐Nicolas Vauthey · 3 shared papers, 2012–2014 · strength 0.09
  10. Peter W. T. Pisters · 3 shared papers, 2012–2014 · strength 0.09
  11. Jeffrey E. Lee · 3 shared papers, 2012–2014 · strength 0.09
  12. Michael James Overman · 2 shared papers, 2013–2017 · strength 0.09
  13. Huamin Wang · 2 shared papers, 2012–2014 · strength 0.06
  14. James L. Abbruzzese · 2 shared papers, 2012–2013 · strength 0.06
  15. Jianhua Zhang · 1 shared paper, 2017 · strength 0.05
  16. Chantale Bernatchez · 1 shared paper, 2017 · strength 0.05
  17. Donastas Sakellariou-Thompson · 1 shared paper, 2017 · strength 0.05
  18. Ya’an Kang · 1 shared paper, 2017 · strength 0.05
  19. Timothy Paul Heffernan · 1 shared paper, 2017 · strength 0.05
  20. Vincent Bernard · 1 shared paper, 2017 · strength 0.05
  21. Patrick Hwu · 1 shared paper, 2017 · strength 0.05
  22. Anirban Maitra · 1 shared paper, 2017 · strength 0.05
  23. Hector A. Alvarez · 1 shared paper, 2017 · strength 0.05
  24. Hop S. Tran Cao · 1 shared paper, 2014 · strength 0.04
  25. Graciela M. Nogueras‐González · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.